Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Alsharifi, Mohammed ^a,c   Furuya, Yoichi ^a   Bowden, Timothy R ^b   Lobigs, Mario ^a   Koskinen, Aulikki ^a   Regner, Matthias ^a   Trinidad, Lee ^b   Boyle, David B ^b   Müllbacher, Arno ^a  

^a Biology and Environment   (Australia)

^b CSIRO   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; GAMMA FLU VACCINE; UNCLASSIFIED DRUG; INACTIVATED VACCINE; INFLUENZA VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CROSS REACTION; FEMALE; GAMMA IRRADIATION; IMMUNE RESPONSE; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; VIRUS INACTIVATION; ANIMAL; BAGG ALBINO MOUSE; CYTOTOXIC T LYMPHOCYTE; EVALUATION; GAMMA RADIATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; PATHOGENICITY; VACCINATION; VIROLOGY;

AVES; FLU VACCINE; INFLUENZA A VIRUS; MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CROSS REACTIONS; FEMALE; GAMMA RAYS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, INACTIVATED;

EID: 65549113823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005336     Document Type: Article

References (23)

1. World Health Organisation (2008) http://www.who.int/csr/disease/ influenza/vaccinerecommendations1/en/index.html.
2. Centers for Disease Control and Prevention (2008) FLUVIEW: A Weekly Influenza Surviellance Report Prepared by the Influenza Division. 2007-2008 Influenza Season Week 20, ending May 17, 2008.
3. Ada GL, Jones PD (1986) The immune response to influenza infection. Curr Top Microbiol Immunol 128: 1-54.
4. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
5. Müllbacher A, Ada GL, Tha Hla R (1988) Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A virus. Immunol Cell Biol 66: 153-157.
6. Elliott LH, McCormick JB, Johnson KM (1982) Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 16: 704-708.
7. Lowy RJ, Vavrina GA, LaBarre DD (2001) Comparison of gamma and neutron radiation inactivation of influenza A virus. Antiviral Res 52: 261-273.
8. Lupton HW (1981) Inactivation of Ebola virus with 60Co irradiation. J Infect Dis 143: 291.
9. International Atomic Energy Agency (1973) The Manual on Radiation Sterilization of Medical and Biological Material: The technical reports series. Vienna. pp 62-63.
10. Reed L, Muench H (1938) A simple method for estimating fifty percent endpoints. Am J Hyg 27: 493-497.
11. Laver WG (1969) Purification of influenza virus HKaS NP, ed. New York and London: Academic Press. pp 82-86.
12. Mullbacher A, Lobigs M, Yewdell JW, Bennink JR, Tha Hla R, et al. (1999) Spontaneous mutation at position 114 in H-2Kd affects cytotoxic T cell responses to influenza virus infection. Eur J Immunol 29: 1228-1234.
13. Heine HG, Trinidad L, Selleck P, Lowther S (2007) Rapid detection of highly pathogenic avian influenza H5N1 virus by TaqMan reverse transcriptase-polymerase chain reaction. Avian Dis 51: 370-372.
14. Bennink J, Effros RB, Doherty PC (1978) Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology 35: 503-509.
15. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436.
16. Weiss AA, Iyer SS (2007) Glycomics Aims To Interpret the Third Molecular Language of Cells: "Some microbes exploit carbohydrate receptors to enter and disrupt particular host cells". Microbe 2: 489-497.
17. Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, et al. (2005) Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23: 5404-5410.
18. Roy S, Kobinger GP, Lin J, Figueredo J, Calcedo R, et al. (2007) Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 25: 6845-6851.
19. Braciale TJ, Yap KL (1978) Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med 147: 1236-1252.
20. Moskophidis D, Kioussis D (1998) Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188: 223-232.
21. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82: 5161-5166.
22. Mullbacher A, Lobigs M, Alsharifi M, Regner M (2006) Cytotoxic T-cell immunity as a target for influenza vaccines. Lancet Infect Dis 6: 255-256.
23. Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A, et al. (2005) Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J Immunol 175: 4635-4640.